Thanks, brikk. Required reading for one and all--not to mention those who, bathed in Western hubris and ignorance withal, dismiss LTC as surgical quackery.
December 20, 2004 Consortium Service Management Group (CTUM.OB) R&D Team Receives Prestigious Award For Work On Live Tissue Welding/Bonding Technology
CORPUS CHRISTI, Texas, Dec. 20 /PRNewswire-FirstCall/ -- Consortium Service Management Group, Inc. (BULLETIN BOARD: CTUM) announced today that 10 researchers of the Ukraine Live Tissue Welding/Bonding research and development team have received by presidential decree the prestigious Governmental Award of Ukraine in the Field of Science and Technology for 2004 for their work on live tissue welding/bonding technology.
CSMG owns the technology and exclusive world rights to the medical device through Live Tissue Connect, Inc., a subsidiary corporation formed for the development and exploitation of the platform technology. The technology was invented and developed at the E.O. Paton Institute of Electric Welding, National Academy of Sciences of Ukraine at Kiev.
The recipients were: Professor Boris E. Paton, academician of the National Academy of Sciences of Ukraine and director of E.O. Paton Institute of Electric Welding, National Academy of Sciences, Ukraine; Academician Vladimir K. Lebedev; Professor Alexei V. Lebedev; and Olga N. Ivanova, who are all with E.O. Paton Institute of Electric Welding, National Academy of Sciences, Ukraine. From the medical clinical trials group, the recipients were: Michael P. Zakharash, M.D., head of Military Medical Department of Security Service of Ukraine; Michael Yu Nechitaylo, M.D., deputy director, Institute for Surgery and Transplantology, M.D.; Yuri A. Furmanov, head of department, Institute for Surgery and Transplantology; Anatoly V. Makarov, M.D., holder of pulmonology chair, P. L. Shuik Kiev Medical Academy for Postgraduate; Sergey E. Podpryatov, M.D., chief surgeon, Kiev City Clinic No. 1; and Yuri M. Zakharash, M.D., assistant professor, O.O. Bogomoletz National Medical University.
CSMG's Tissue Welding/Bonding Technology
CSMG's patented tissue-bonding device bonds through radiofrequency fusion and reconnects living soft biological tissue (organs) without the use of foreign matter or conventional wound-closing devices such as sutures, staples or glues.
In Ukraine, almost 3,000 (now, 5000) successful human surgeries in clinical trials have been completed using various procedures. Surgeons at four Ukraine hospitals are using the tissue-bonding technology in clinical trials and performing both open and laparoscopic surgical procedures. Procedures so far have involved the bonding and reconnecting of incised or separated human soft tissues in a variety of organs while restoring the normal function of the body organ or tissue.
CSMG maintains offices in Corpus Christi, Texas; Oklahoma City, Okla.; and Kiev, Ukraine. The company website is http://www.ctum.com/
News 
Market Data 
Discover 
